Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

cheong kim chuan sdn bhd - nutmeg oil -

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - nutmeg allergen extract - solution for skin-prick test

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

prime pharmaceutical sdn. bhd. - nutmeg oil; menthol -

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

genentech, inc. - somatropin (unii: nqx9kb6pcl) (somatropin - unii:nqx9kb6pcl) - somatropin 10 mg in 2 ml - growth hormone deficiency (ghd) - nutropin aq® is indicated for the treatment of pediatric patients who have growth failure due to inadequate secretion of endogenous growth hormone (gh). growth failure secondary to chronic kidney disease (ckd) - nutropin aq is indicated for the treatment of growth failure associated with ckd up to the time of renal transplantation. nutropin aq therapy should be used in conjunction with optimal management of ckd. idiopathic short stature (iss) - nutropin aq is indicated for the treatment of iss, also called non-ghd short stature, defined by height sds ≤ –2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range, in pediatric patients whose epiphyses are not closed and for whom diagnostic evaluation excludes other causes associated with short stature that should be observed or treated by other means. short stature associated with turner syndrome (ts) - nutropin aq is indicated for the treatment of short stature associated wit

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

ipsen pty ltd - somatropin, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; phenol; polysorbate 20; sodium citrate dihydrate; citric acid; sodium chloride - long-term treatment of children with growth failure due to inadequate endogenous growth hormone secretion. long-term treatment of growth failure associated with turner syndrome. treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation. treatment of adults with severe growth hormone deficiency as diagnosed in the insulin tolerance test for growth hormone deficiency and defined by peak gh concentrations of less than 2.5 ng/ml.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

somatropin -

Eiropas Savienība - angļu - EMA (European Medicines Agency)

ipsen pharma - somatropin - turner syndrome; dwarfism, pituitary - pituitary and hypothalamic hormones and analogues - long-term treatment of children with growth failure due to inadequate endogenous growth hormone secretion.long-term treatment of growth failure associated with turner syndrome.treatment of prepubertal children with growth failure associated with chronic renal insufficiency up to the time of renal transplantation.replacement of endogenous growth hormone in adults with growth hormone deficiency of either childhood or adult-onset etiology. growth hormone deficiency should be confirmed appropriately prior to treatment.

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nutrigo sdn. bhd. - coenzyme q10 (ubidecarenone); zinc oxide; tocopheryl acid succinate, d-alpha -

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nutrigo sdn. bhd. - fish oil -

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nutrigo sdn. bhd. - fish oil -